Moses Mukosha
Overview
Explore the profile of Moses Mukosha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lubeya M, Sinyani A, Mukosha M, Lindsay B, Mumbula E, Agbakwuru C, et al.
Cancer Control
. 2024 Dec;
31:10732748241307361.
PMID: 39710618
Background: Despite Zambia implementing the World Health Organisation's (WHO) tri-pillar cervical cancer prevention goals 90-70-90 Prevent, Screen, and Treat, cervical cancer claims 2000 lives annually and reigns as the most...
2.
Kabaya Z, Omar R, Kumwenda A, Muyangwa-Semenova M, Mukosha M
Pan Afr Med J
. 2024 Nov;
48:136.
PMID: 39554261
Introduction: pre-eclampsia affects an estimated 8% of pregnant women and contributes to over 12% of global maternal deaths. High-sensitivity C-reactive protein (hs-CRP) is a potential marker of pre-eclampsia. However, little...
3.
Mukosha M, Bramham K, Zambala L, Lubeya M, Mercy Mwangu L, Mwila C, et al.
Pregnancy Hypertens
. 2024 Oct;
38:101163.
PMID: 39388773
Objective: To assess Healthcare providers (HCPs') knowledge of cardiovascular disease risk after preeclampsia across five healthcare facilities in Lusaka, Zambia. Study Design: A cross-sectional study was conducted at selected health...
4.
Kampamba M, Nelumbu N, Hikaambo C, Mudenda S, Hangoma J, Kunda M, et al.
Health Sci Rep
. 2024 Sep;
7(9):e70060.
PMID: 39257911
Background And Aims: Despite a quick rollout of PrEP as a preventive method against Human Immunodeficiency Virus (HIV) infections in Zambia, adolescent and young adult populations have remained very vulnerable...
5.
Mukosha M, Hatcher A, Lubeya M, Maposa I, Chi B, Mutale W
PLoS One
. 2024 Sep;
19(9):e0309915.
PMID: 39231156
Background: Persistent hypertension is common after preeclampsia and is causally tied to later cardiovascular risks. This study examined whether being HIV-infected and on antiretroviral therapy (ART) is associated with persistent...
6.
Jere E, Munkombwe D, Mukosha M, Mudenda S, Kalungia A, Chabalenge B
J Med Access
. 2024 Jul;
8:27550834241266755.
PMID: 39071988
Background: There is growing concern in sub-Saharan Africa that poor-quality antimicrobial medicines may negate management of infectious diseases of public health importance should they fail to meet the set criteria...
7.
Lubeya M, Munakampe M, Mwila M, Makasa M, Mukosha M, Jacobs C, et al.
BMC Womens Health
. 2024 Jul;
24(1):414.
PMID: 39039469
Background: Despite attempts to increase Universal Health Coverage, availability, accessibility, acceptability, and quality-related challenges remain barriers to receiving essential services by women who need them. We aimed to explore the...
8.
Daka V, Mukosha M, Zimba S, Phiri A
BMJ Open
. 2024 Jul;
14(6):e084582.
PMID: 38950992
Background: Toxoplasmosis is a zoonotic parasitic disease caused by . It has a wide host range and is capable of vertical transmission in pregnant women, which may lead to undesirable...
9.
Lubeya M, Mwanahamuntu M, Chibwesha C, Mukosha M, Kawonga M
Vaccines (Basel)
. 2024 May;
12(5).
PMID: 38793793
The human papillomavirus (HPV) vaccine is effective in cervical cancer prevention. However, many barriers to uptake exist and strategies to overcome them are needed. Therefore, this study aimed to select...
10.
Mukosha M, Hatcher A, Mutale W, Lubeya M, Conklin J, Chi B
Front Glob Womens Health
. 2024 Mar;
5:1315763.
PMID: 38495126
Background: Hypertensive disorders of pregnancy can lead to persistent hypertension (pHTN) in the months and even years following delivery. However, its prevalence in low- and middle-income countries (LMICs) is not...